Molecular and clinical characterization of new patient with 1,08 Mb deletion in 10p15.3 region
Abstract Background Three distinct contiguous gene deletion syndromes are located at 10p chromosomal region. The deletion, involving 10p15.3 region, has been characterized by (DeScipio et al., Am J Med Genet A 158A:2152-61, 2012). However, because of the variation in size of the described deletions...
Main Authors: | Anna Poluha, Joanna Bernaciak, Ilona Jaszczuk, Marta Kędzior, Beata Anna Nowakowska |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-09-01
|
Series: | Molecular Cytogenetics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13039-017-0336-2 |
Similar Items
-
Symptomatic metastasis prediction with serial measurements of CA 15.3 in primary breast cancer patients
by: Amir Bahrami-Ahmadi, et al.
Published: (2012-01-01) -
Coumarin 153 Dynamics in Ethylammonium Nitrate: The Effects of Dilution with Methanol
by: Mark P. Heitz, et al.
Published: (2021-12-01) -
Primary Cutaneous Mucinous Carcinoma Monitoring: A Role for CA15.3 and CEA?
by: Antonin Ginguay, et al.
Published: (2022-12-01) -
Identification of candidate genes of intellectual disability by single-gene deletions/amplifications mapping using chromosomal microarray analysis
by: A. Kashevarova, et al.
Published: (2022-06-01) -
Tumor biomarkers CEA, CA19.9, CA15.3 and AFP levels in the serum of patients with COVID-19
by: Abubaker H. Ali, et al.
Published: (2022-04-01)